These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9406918)

  • 1. Selective increase in somatostatin mRNA expression in human basal ganglia in Parkinson's disease.
    Eve DJ; Nisbet AP; Kingsbury AE; Temlett J; Marsden CD; Foster OJ
    Brain Res Mol Brain Res; 1997 Oct; 50(1-2):59-70. PubMed ID: 9406918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate decarboxylase-67 messenger RNA expression in normal human basal ganglia and in Parkinson's disease.
    Nisbet AP; Eve DJ; Kingsbury AE; Daniel SE; Marsden CD; Lees AJ; Foster OJ
    Neuroscience; 1996 Nov; 75(2):389-406. PubMed ID: 8931005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal ganglia neuronal nitric oxide synthase mRNA expression in Parkinson's disease.
    Eve DJ; Nisbet AP; Kingsbury AE; Hewson EL; Daniel SE; Lees AJ; Marsden CD; Foster OJ
    Brain Res Mol Brain Res; 1998 Dec; 63(1):62-71. PubMed ID: 9838046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and modulation of histamine H(3) receptors in basal ganglia and frontal cortex of healthy controls and patients with Parkinson's disease.
    Anichtchik OV; Peitsaro N; Rinne JO; Kalimo H; Panula P
    Neurobiol Dis; 2001 Aug; 8(4):707-16. PubMed ID: 11493035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys.
    Morin N; Morissette M; Grégoire L; Gomez-Mancilla B; Gasparini F; Di Paolo T
    Neuropharmacology; 2013 Oct; 73():216-31. PubMed ID: 23756168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's disease.
    Kunikowska G; Jenner P
    Brain Res; 2003 Apr; 968(2):206-18. PubMed ID: 12663090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets.
    Lastres-Becker I; Cebeira M; de Ceballos ML; Zeng BY; Jenner P; Ramos JA; Fernández-Ruiz JJ
    Eur J Neurosci; 2001 Dec; 14(11):1827-32. PubMed ID: 11860478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia.
    Riahi G; Morissette M; Samadi P; Parent M; Di Paolo T
    Biochem Pharmacol; 2013 Oct; 86(7):970-8. PubMed ID: 23954709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide synthase mRNA expression in human subthalamic nucleus, striatum and globus pallidus: implications for basal ganglia function.
    Nisbet AP; Foster OJ; Kingsbury A; Lees AJ; Marsden CD
    Brain Res Mol Brain Res; 1994 Mar; 22(1-4):329-32. PubMed ID: 7516995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease.
    Griffiths PD; Crossman AR
    Dementia; 1993; 4(2):61-5. PubMed ID: 8358514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activity of cerebellar and basal ganglia-thalamic neurons is reduced in parkinsonism.
    Rolland AS; Herrero MT; Garcia-Martinez V; Ruberg M; Hirsch EC; François C
    Brain; 2007 Jan; 130(Pt 1):265-75. PubMed ID: 17148469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B; Crossman AR; Brotchie JM
    Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
    Morissette M; Morin N; Grégoire L; Rajput A; Rajput AH; Di Paolo T
    Biochem Pharmacol; 2016 Jun; 109():62-69. PubMed ID: 27038656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nigrostriatal denervation and L-dopa therapy on the GABAergic neurons in the striatum in MPTP-treated monkeys and Parkinson's disease: an in situ hybridization study of GAD67 mRNA.
    Levy R; Herrero MT; Ruberg M; Villares J; Faucheux B; Guridi J; Guillen J; Luquin MR; Javoy-Agid F; Obeso JA
    Eur J Neurosci; 1995 Jun; 7(6):1199-209. PubMed ID: 7582093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased neuropeptide Y mRNA expression in striatum in Parkinson's disease.
    Cannizzaro C; Tel BC; Rose S; Zeng BY; Jenner P
    Brain Res Mol Brain Res; 2003 Feb; 110(2):169-76. PubMed ID: 12591154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson's disease.
    Hurley MJ; Mash DC; Jenner P
    Brain Res Mol Brain Res; 2001 Mar; 87(2):271-9. PubMed ID: 11245931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain.
    Hurley MJ; Mash DC; Jenner P
    J Neural Transm (Vienna); 2003 Nov; 110(11):1279-88. PubMed ID: 14628192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease.
    Henry B; Duty S; Fox SH; Crossman AR; Brotchie JM
    Exp Neurol; 2003 Oct; 183(2):458-68. PubMed ID: 14552886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of glutamate receptors in the human and rat basal ganglia: effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion.
    Bernard V; Gardiol A; Faucheux B; Bloch B; Agid Y; Hirsch EC
    J Comp Neurol; 1996 May; 368(4):553-68. PubMed ID: 8744443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study.
    Vila M; Levy R; Herrero MT; Faucheux B; Obeso JA; Agid Y; Hirsch EC
    Neuroscience; 1996 Apr; 71(4):903-12. PubMed ID: 8684621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.